{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:08:36Z","timestamp":1774393716802,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00380-020-01651-8","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T15:03:48Z","timestamp":1592924628000},"page":"1727-1733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Switching from Warfarin to rivaroxaban induces sufficiency of vitamin K and reduction of arterial stiffness in patients with atrial fibrillation"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5686-4324","authenticated-orcid":false,"given":"Yuji","family":"Ikari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumie","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Kiyooka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Furuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigemitsu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"key":"1651_CR1","doi-asserted-by":"publisher","first-page":"j5058","DOI":"10.1136\/bmj.j5058","volume":"359","author":"JA Lopez-Lopez","year":"2017","unstructured":"Lopez-Lopez JA, Sterne JAC, Thom HHZ, Higgins JPT, Hingorani AD, Okoli GN, Davies PA, Bodalia PN, Bryden PA, Welton NJ, Hollingworth W, Caldwell DM, Savovic J, Dias S, Salisbury C, Eaton D, Stephens-Boal A, Sofat R (2017) Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis. BMJ 359:j5058","journal-title":"BMJ"},{"key":"1651_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/01.ATV.20.2.317","volume":"20","author":"PA Price","year":"2000","unstructured":"Price PA, Faus SA, Williamson MK (2000) Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Thromb Vasc Biol 20:317\u2013327","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1651_CR3","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1161\/01.ATV.18.9.1400","volume":"18","author":"PA Price","year":"1998","unstructured":"Price PA, Faus SA, Williamson MK (1998) Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 18:1400\u20131407","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1651_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1159\/000075344","volume":"40","author":"HM Spronk","year":"2003","unstructured":"Spronk HM, Soute BA, Schurgers LJ, Thijssen HH, De Mey JG, Vermeer C (2003) Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. J Vasc Res 40:531\u2013537","journal-title":"J Vasc Res"},{"key":"1651_CR5","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1182\/blood-2006-07-035345","volume":"109","author":"LJ Schurgers","year":"2007","unstructured":"Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C (2007) Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 109:2823\u20132831","journal-title":"Blood"},{"key":"1651_CR6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/ajh\/hpv127","volume":"29","author":"ML Meyer","year":"2016","unstructured":"Meyer ML, Tanaka H, Palta P, Patel MD, Camplain R, Couper D, Cheng S, Al Qunaibet A, Poon AK, Heiss G (2016) Repeatability of central and peripheral pulse wave velocity measures: the atherosclerosis risk in communities (ARIC) study. Am J Hypertens 29:470\u2013475","journal-title":"Am J Hypertens"},{"key":"1651_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/MBP.0000000000000052","volume":"19","author":"L Tripkovic","year":"2014","unstructured":"Tripkovic L, Hart KH, Frost GS, Lodge JK (2014) Interindividual and intraindividual variation in pulse wave velocity measurements in a male population. Blood Press Monit 19:233\u2013241","journal-title":"Blood Press Monit"},{"key":"1651_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/hr.2015.8","volume":"38","author":"N Saji","year":"2015","unstructured":"Saji N, Kimura K, Yagita Y, Kawarai T, Shimizu H, Kita Y (2015) Comparison of arteriosclerotic indicators in patients with ischemic stroke: ankle-brachial index, brachial-ankle pulse wave velocity and cardio-ankle vascular index. Hypertens Res 38:323\u2013328","journal-title":"Hypertens Res"},{"key":"1651_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-019-01998-3","author":"HG Chen","year":"2019","unstructured":"Chen HG, Sheng LT, Zhang YB, Cao AL, Lai YW, Kunutsor SK, Jiang L, Pan A (2019) Association of vitamin K with cardiovascular events and all-cause mortality: a systematic review and meta-analysis. Eur J Nutr. https:\/\/doi.org\/10.1007\/s00394-019-01998-3","journal-title":"Eur J Nutr"},{"key":"1651_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12937-016-0175-8","volume":"15","author":"Y Ikari","year":"2016","unstructured":"Ikari Y, Torii S, Shioi A, Okano T (2016) Impact of menaquinone-4 supplementation on coronary artery calcification and arterial stiffness: an open label single arm study. Nutr J 15:53","journal-title":"Nutr J"},{"key":"1651_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jash.2017.07.001","volume":"11","author":"AG Mansour","year":"2017","unstructured":"Mansour AG, Hariri E, Daaboul Y, Korjian S, El Alam A, Protogerou AD, Kilany H, Karam A, Stephan A, Bahous SA (2017) Vitamin K2 supplementation and arterial stiffness among renal transplant recipients-a single-arm, single-center clinical trial. J Am Soc Hypertens 11:589\u2013597","journal-title":"J Am Soc Hypertens"},{"key":"1651_CR12","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1160\/TH14-08-0675","volume":"113","author":"MH Knapen","year":"2015","unstructured":"Knapen MH, Braam LA, Drummen NE, Bekers O, Hoeks AP, Vermeer C (2015) Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial. Thromb Haemost 113:1135\u20131144","journal-title":"Thromb Haemost"},{"key":"1651_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1161\/HYPERTENSIONAHA.115.05177","volume":"66","author":"E Pivin","year":"2015","unstructured":"Pivin E, Ponte B, Pruijm M, Ackermann D, Guessous I, Ehret G, Liu YP, Drummen NE, Knapen MH, Pechere-Bertschi A, Paccaud F, Mohaupt M, Vermeer C, Staessen JA, Vogt B, Martin PY, Burnier M, Bochud M (2015) Inactive matrix Gla-protein is associated with arterial stiffness in an adult population-based study. Hypertension 66:85\u201392","journal-title":"Hypertension"},{"key":"1651_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/ajh\/hpw146","volume":"30","author":"M Sardana","year":"2017","unstructured":"Sardana M, Vasim I, Varakantam S, Kewan U, Tariq A, Koppula MR, Syed AA, Beraun M, Drummen NE, Vermeer C, Akers SR, Chirinos JA (2017) Inactive matrix gla-protein and arterial stiffness in type 2 diabetes mellitus. Am J Hypertens 30:196\u2013201","journal-title":"Am J Hypertens"},{"key":"1651_CR15","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/jhh.2015.55","volume":"30","author":"O Mayer Jr","year":"2016","unstructured":"Mayer O Jr, Seidlerova J, Wohlfahrt P, Filipovsky J, Vanek J, Cifkova R, Windrichova J, Topolcan O, Knapen MH, Drummen NE, Vermeer C (2016) Desphospho-uncarboxylated matrix Gla protein is associated with increased aortic stiffness in a general population. J Hum Hypertens 30:418\u2013423","journal-title":"J Hum Hypertens"},{"key":"1651_CR16","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/ajh\/hpy079","volume":"31","author":"H Puzantian","year":"2018","unstructured":"Puzantian H, Akers SR, Oldland G, Javaid K, Miller R, Ge Y, Ansari B, Lee J, Suri A, Hasmath Z, Townsend R, Chirinos JA (2018) Circulating dephospho-uncarboxylated matrix gla-protein is associated with kidney dysfunction and arterial stiffness. Am J Hypertens 31:988\u2013994","journal-title":"Am J Hypertens"},{"key":"1651_CR17","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1161\/HYPERTENSIONAHA.118.12157","volume":"73","author":"Z Hashmath","year":"2019","unstructured":"Hashmath Z, Lee J, Gaddam S, Ansari B, Oldland G, Javaid K, Mustafa A, Vasim I, Akers S, Chirinos JA (2019) Vitamin K status, warfarin use, and arterial stiffness in heart failure. Hypertension 73:364\u2013370","journal-title":"Hypertension"},{"key":"1651_CR18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM, Investigators RA (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883\u2013891","journal-title":"N Engl J Med"},{"key":"1651_CR19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.atherosclerosis.2015.03.023","volume":"242","author":"T Hara","year":"2015","unstructured":"Hara T, Fukuda D, Tanaka K, Higashikuni Y, Hirata Y, Nishimoto S, Yagi S, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Sata M (2015) Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice. Atherosclerosis 242:639\u2013646","journal-title":"Atherosclerosis"},{"key":"1651_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/17512433.2019.1637732","volume":"12","author":"M Sanmartin","year":"2019","unstructured":"Sanmartin M, Bellmunt S, Cosin-Sales J, Garcia-Moll X, Riera-Mestre A, Almendro-Delia M, Hernandez JL, Lozano F, Mazon P, Suarez Fernandez C (2019) Role of rivaroxaban in the prevention of atherosclerotic events. Expert Rev Clin Pharmacol 12:771\u2013780","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1651_CR21","doi-asserted-by":"publisher","DOI":"10.1159\/000499975:1-10","author":"M Maeda","year":"2019","unstructured":"Maeda M, Tsuboi T, Hayashi T (2019) An inhibitor of activated blood coagulation factor X shows anti-endothelial senescence and anti-atherosclerotic effects. J Vasc Res. https:\/\/doi.org\/10.1159\/000499975:1-10","journal-title":"J Vasc Res"},{"key":"1651_CR22","doi-asserted-by":"publisher","first-page":"e012195","DOI":"10.1161\/JAHA.119.012195","volume":"8","author":"H Ichikawa","year":"2019","unstructured":"Ichikawa H, Shimada M, Narita M, Narita I, Kimura Y, Tanaka M, Osanai T, Okumura K, Tomita H (2019) Rivaroxaban, a direct factor xa inhibitor, ameliorates hypertensive renal damage through inhibition of the inflammatory response mediated by protease-activated receptor pathway. J Am Heart Assoc 8:e012195","journal-title":"J Am Heart Assoc"},{"key":"1651_CR23","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00380-017-0950-2","volume":"32","author":"S Namba","year":"2017","unstructured":"Namba S, Yamaoka-Tojo M, Kakizaki R, Nemoto T, Fujiyoshi K, Hashikata T, Kitasato L, Hashimoto T, Kameda R, Meguro K, Shimohama T, Tojo T, Ako J (2017) Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation. Heart Vessels 32:977\u2013982","journal-title":"Heart Vessels"}],"updated-by":[{"DOI":"10.1007\/s00380-020-01665-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000}}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-020-01651-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-020-01651-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-020-01651-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T23:40:04Z","timestamp":1624405204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-020-01651-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1651"],"URL":"https:\/\/doi.org\/10.1007\/s00380-020-01651-8","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00380-020-01665-2","asserted-by":"object"}]},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,23]]},"assertion":[{"value":"30 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original publication of the article,one of the author\u2019s name was published incorrectly as \u201cTakamoto Furuki\u201d.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interests. This study was supported by Bayer Pharmaceuticals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}